Technology | February 20, 2015

System automatically verifies accurate delivery of every fraction in course of treatment

February 20, 2015 Mobius Medical Systems LP announced the release of Mobius3D version 1.5. For users with the MobiusFX treatment verification module, the newest version of Mobius3D automatically verifies accurate delivery of every fraction in a patient’s course of treatment. A Treatment Summary report displays an interactive analysis of each delivered fraction. If any discrepancies are found, Mobius3D determines the 3-D dosimetric impact to the patient.

Version 1.5 also adds support for the Mobius Verification Phantom (MVP). The MVP contains seven ion chamber measurement points and a film plane. Its geometry is built into Mobius3D, allowing quality assurance (QA) plans measured using the MVP to be automatically calculated and verified in Mobius3D. The MVP adds flexibility in the Mobius3D ecosystem for commissioning, spot checks, easy investigation into QA failures and as a secondary intensity modulated radiation therapy (IMRT) QA device.

For more information: www.mobiusmed.com


Related Content

News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
Subscribe Now